Tag #Hormone Therapy

Showing 1 to 8 of 8 results

dailymail.co.uk

🌐 85% Global Worthiness

Jul 19, 04:13

Two-Week Breast Cancer Test Predicts Recurrence, Personalizes Treatment

A new test, after two weeks of hormone therapy, identifies breast cancer patients (6% of 213 studied) whose Luminal B tumors don't change subtype, indicating a need for intensive treatment; this impacts around 200,000 ER-positive, HER2-positive breast cancer cases globally yearly.

Two-Week Breast Cancer Test Predicts Recurrence, Personalizes Treatment

A new test, after two weeks of hormone therapy, identifies breast cancer patients (6% of 213 studied) whose Luminal B tumors don't change subtype, indicating a need for intensive treatment; this impacts around 200,000 ER-positive, HER2-positive breast cancer cases globally yearly.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of this new breast cancer test on patient care and treatment strategies?

A new test accurately predicts breast cancer recurrence risk after two weeks of hormone therapy, sparing patients unnecessary treatment. The test identifies Luminal B tumors, which account for 6% of the 213 patients studied, as resistant to short-term therapy and needing more intensive care. This personalized approach refines breast cancer classification, optimizing treatment strategies.

foxnews.com

🌐 85% Global Worthiness

May 20, 22:11

Biden's Aggressive Prostate Cancer: Hormone-Sensitive, Treatment Options Under Review

Former President Joe Biden has been diagnosed with an aggressive, hormone-sensitive prostate cancer with bone metastasis, prompting consideration of various treatment options.

Biden's Aggressive Prostate Cancer: Hormone-Sensitive, Treatment Options Under Review

Former President Joe Biden has been diagnosed with an aggressive, hormone-sensitive prostate cancer with bone metastasis, prompting consideration of various treatment options.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the hormone sensitivity of Biden's prostate cancer affect treatment options and prognosis?

The hormone-sensitive nature of Biden's cancer is common; most prostate cancers initially depend on testosterone. Treatment typically involves androgen deprivation therapy, lowering testosterone levels to stop cancer growth. While initially effective, hormone-sensitive cancers eventually become resistant, usually within a couple of years.

abcnews.go.com

🌐 85% Global Worthiness

Mar 17, 19:17

Gender-Affirming Hormone Therapy Reduces Depression Risk in Transgender Adults

A study of 3,592 transgender and gender-diverse adults found that those receiving gender-affirming hormone therapy had a 15% lower risk of moderate-to-severe depression over four years, highlighting the treatment's mental health benefits and the need for accessible care amid growing restrictions.

Gender-Affirming Hormone Therapy Reduces Depression Risk in Transgender Adults

A study of 3,592 transgender and gender-diverse adults found that those receiving gender-affirming hormone therapy had a 15% lower risk of moderate-to-severe depression over four years, highlighting the treatment's mental health benefits and the need for accessible care amid growing restrictions.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the findings of this study connect to broader concerns about access to gender-affirming care and the mental health implications of legislative restrictions?

The study, published in JAMA Network Open, reveals a significant correlation between gender-affirming hormone therapy and lower depression risk among transgender individuals. This finding directly counters the higher depression rates (two to three times greater) observed in this population, suggesting the therapy plays a crucial role in mitigating mental health disparities. The observed effect is noteworthy given that the study controlled for other factors influencing mood.

dailymail.co.uk

🌐 85% Global Worthiness

Mar 6, 04:13

Spanish Doctors Fuel UK Children's Hormone Crisis

Two Spanish doctors are prescribing potentially harmful cross-sex hormones to British children via GenderGP, a private clinic, prompting a legal threat against the Health Secretary and raising concerns about long-term health impacts and regulatory gaps.

Spanish Doctors Fuel UK Children's Hormone Crisis

Two Spanish doctors are prescribing potentially harmful cross-sex hormones to British children via GenderGP, a private clinic, prompting a legal threat against the Health Secretary and raising concerns about long-term health impacts and regulatory gaps.

Progress

80% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do post-Brexit regulations contribute to the ability of foreign doctors to prescribe these hormones to British children?

The doctors' actions are enabled by post-Brexit regulations allowing prescriptions from EEA-qualified doctors. Legal action threatens the Health Secretary if private clinics, both UK and foreign, aren't banned from prescribing these hormones to minors. This follows concerns raised by an independent review highlighting the potential harm of these drugs.

abcnews.go.com

🌐 85% Global Worthiness

Jun 4, 04:14

Federal Judge Blocks Trump Order Halting Hormone Therapy for Transgender Inmates

A federal judge blocked President Trump's executive order halting hormone therapy for transgender inmates in federal prisons, citing a federal law prohibiting the arbitrary deprivation of medication deemed necessary by prison medical staff; over 600 inmates receive this therapy.

Federal Judge Blocks Trump Order Halting Hormone Therapy for Transgender Inmates

A federal judge blocked President Trump's executive order halting hormone therapy for transgender inmates in federal prisons, citing a federal law prohibiting the arbitrary deprivation of medication deemed necessary by prison medical staff; over 600 inmates receive this therapy.

Progress

40% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the judge's ruling on transgender inmates in federal prisons?

A federal judge ruled that the Bureau of Prisons must continue providing hormone therapy and other accommodations to transgender inmates, blocking an executive order from President Trump that disrupted their medical treatment. The judge found that denying this care is a violation of federal law and that the order lacked justification. Over 600 inmates receive this therapy.

smh.com.au

🌐 85% Global Worthiness

Mar 22, 10:10

Queensland Pauses Hormone Therapy for Gender Dysphoria Patients Amidst Consent Concerns

Queensland Health Minister Tim Nicholls paused hormone therapy for new young gender dysphoria patients in Cairns following allegations of unauthorized services to 42 pediatric patients, 17 of whom received hormone therapy; a risk assessment revealed consent issues, and the pause remains indefinite d...

Queensland Pauses Hormone Therapy for Gender Dysphoria Patients Amidst Consent Concerns

Queensland Health Minister Tim Nicholls paused hormone therapy for new young gender dysphoria patients in Cairns following allegations of unauthorized services to 42 pediatric patients, 17 of whom received hormone therapy; a risk assessment revealed consent issues, and the pause remains indefinite d...

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the consent practices at the Cairns Sexual Health Service compare with those of the Queensland Children's Gender Service, and what are the implications of these differences for patient care?

The pause, initially presented as a temporary measure pending a 10-month review, remains indefinite due to the lack of a designated reviewer and unresolved questions regarding the review's scope. This decision contrasts with the federal government's approach, which requested a national review. The risk assessment also pointed to limited private alternatives, raising concerns about potential risks if public services are discontinued.

us.cnn.com

🌐 85% Global Worthiness

Mar 17, 22:12

Hormone Therapy Linked to Reduced Depression Risk in Transgender Individuals

A study of 3,592 transgender, nonbinary, and gender-diverse patients at two community health centers in Boston and New York City found that those prescribed hormone therapy had a 15% lower risk of moderate-to-severe depressive symptoms over four years compared to those who weren't; this highlights t...

Hormone Therapy Linked to Reduced Depression Risk in Transgender Individuals

A study of 3,592 transgender, nonbinary, and gender-diverse patients at two community health centers in Boston and New York City found that those prescribed hormone therapy had a 15% lower risk of moderate-to-severe depressive symptoms over four years compared to those who weren't; this highlights t...

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How do the findings of this study relate to the broader context of mental health disparities and discrimination faced by the transgender community?

The study's findings connect to broader concerns about mental health disparities within the transgender community. The 33% depression rate among transgender individuals, significantly higher than the 8.3% rate in the general population, underscores the critical need for accessible and affirmative healthcare. This research demonstrates that hormone therapy can be a valuable tool in addressing these disparities.

bbc.com

🌐 85% Global Worthiness

Dec 20, 01:08

Court to Maintain Oversight of Teen's Cross-Sex Hormone Case

A UK Court of Appeal ruled that it will continue to oversee a case involving a 16-year-old seeking cross-sex hormones, despite the child's capacity to consent, due to concerns about rapidly changing regulations and potential future disagreements. This follows a lower court's dismissal of the mother'...

Court to Maintain Oversight of Teen's Cross-Sex Hormone Case

A UK Court of Appeal ruled that it will continue to oversee a case involving a 16-year-old seeking cross-sex hormones, despite the child's capacity to consent, due to concerns about rapidly changing regulations and potential future disagreements. This follows a lower court's dismissal of the mother'...

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of the Court of Appeal's decision regarding a 16-year-old's access to cross-sex hormones?

A UK mother successfully appealed a lower court's decision, maintaining court oversight of her 16-year-old child's request for cross-sex hormones. The Court of Appeal acknowledged the child's capacity to consent but highlighted potential future disagreements and the rapidly evolving regulatory landscape surrounding gender services. The ruling underscores ongoing uncertainty in this area, especially concerning private clinics.

Showing 1 to 8 of 8 results